| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Greenlee was Program Director for Cancer Surveillance in the Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA. He is currently a lead scientist with the Marshfield Medical Research Foundation, Marshfield, WI.
Ms. Hill-Harmon is an Epidemiologist in the Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Murray is Manager, Surveillance Data Systems, in the Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Thun is Vice-President of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Each year the American Cancer Society compiles estimates of the number of new cancer cases and deaths expected in the US in the current year and the most recent data on cancer incidence, mortality, and survival. An estimated 1,268,000 new cases of cancer will be diagnosed in the year 2001 and an estimated 553,400 Americans will die from cancer. Overall cancer incidence and death rates have continued to decrease in men and women since the early 1990s, and the decline in overall cancer mortality has been greater in recent years. Despite reductions in age-adjusted rates of cancer death, the total number of recorded cancer deaths in the US continues to increase, due to an aging and expanding population. Large disparities in cancer incidence and mortality across racial/ethnic groups continue. Black men and women experience higher incidence of cancer and poorer survival than white men and women. The disparity in survival reflects both diagnosis of cancer at later disease stages, and poorer survival within each stage of diagnosis.
This article has been cited by other articles:
|
|
 |
|
  M.-F. Penet, A. P. Pathak, V. Raman, P. Ballesteros, D. Artemov, and Z. M. Bhujwalla Noninvasive Multiparametric Imaging of Metastasis-Permissive Microenvironments in a Human Prostate Cancer Xenograft Cancer Res., November 15, 2009; 69(22): 8822 - 8829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-Y. Choi, W. E. Barlow, K. S. Albain, C.-C. Hong, J. G. Blanco, R. B. Livingston, W. Davis, J. M. Rae, I-T. Yeh, L. F. Hutchins, et al. Nitric Oxide Synthase Variants and Disease-Free Survival among Treated and Untreated Breast Cancer Patients in a Southwest Oncology Group Clinical Trial Clin. Cancer Res., August 15, 2009; 15(16): 5258 - 5266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. P. Rogozina, M. J.L. Bonorden, J. P. Grande, and M. P. Cleary Serum Insulin-like Growth Factor-I and Mammary Tumor Development in Ad libitum-Fed, Chronic Calorie-Restricted, and Intermittent Calorie-Restricted MMTV-TGF-{alpha} Mice Cancer Prevention Research, August 1, 2009; 2(8): 712 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Saidak, R. Mentaverri, and E. M. Brown The Role of the Calcium-Sensing Receptor in the Development and Progression of Cancer Endocr. Rev., April 1, 2009; 30(2): 178 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bandres, N. Bitarte, F. Arias, J. Agorreta, P. Fortes, X. Agirre, R. Zarate, J. A. Diaz-Gonzalez, N. Ramirez, J. J. Sola, et al. microRNA-451 Regulates Macrophage Migration Inhibitory Factor Production and Proliferation of Gastrointestinal Cancer Cells Clin. Cancer Res., April 1, 2009; 15(7): 2281 - 2290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-K. Kim, J. S. Yang, K. Maiti, J.-I. Hwang, K. Kim, D. Seen, Y. Ahn, C. Lee, B.-C. Kang, H. B. Kwon, et al. A Gonadotropin-Releasing Hormone-II Antagonist Induces Autophagy of Prostate Cancer Cells Cancer Res., February 1, 2009; 69(3): 923 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. FOUNTZILAS, A. BAMIAS, A. KALOGERA-FOUNTZILA, G. KARAYANNOPOULOU, M. BOBOS, E. ATHANASSIOU, K. T. KALOGERAS, C. TOLIS, P. TSEKERIS, P. PAPAKOSTAS, et al. Induction Chemotherapy with Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy in Patients with Inoperable Non-nasopharyngeal Carcinoma of the Head and Neck Anticancer Res, February 1, 2009; 29(2): 529 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Saad, J. L. Lindner, Y. Liu, and J. F. Silverman Lymphangiogenesis in Esophageal Adenocarcinomas--Lymphatic Vessel Density as Prognostic Marker in Esophageal Adenocarcinoma Am J Clin Pathol, January 1, 2009; 131(1): 92 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Chen, H.-H. Lin, T.-A. Chiang, J.-D. Hsu, H.-H. Ho, Y.-C. Lee, and C.-J. Wang Gaseous Nitrogen Oxide Promotes Human Lung Cancer Cell Line A549 Migration, Invasion, and Metastasis via iNOS-Mediated MMP-2 Production Toxicol. Sci., December 1, 2008; 106(2): 364 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yuan, J. Ma, H. Zheng, T. Shi, W. Sun, Q. Zhang, D. Lin, K. Zhang, J. He, Y. Mao, et al. Overexpression of OLC1, Cigarette Smoke, and Human Lung Tumorigenesis J Natl Cancer Inst, November 19, 2008; 100(22): 1592 - 1605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Holder Analysis of chloroethane toxicity and carcinogenicity including a comparison with bromoethane Toxicology and Industrial Health, November 1, 2008; 24(10): 655 - 675. [Abstract] [PDF]
|
|
|
|
|
|
R. E. Coleman, T. A. Guise, A. Lipton, G. D. Roodman, J. R. Berenson, J.-J. Body, B. F. Boyce, L. M. Calvi, P. Hadji, E. V. McCloskey, et al. Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference Clin. Cancer Res., October 15, 2008; 14(20): 6387 - 6395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Mack, M. W. Redman, K. Chansky, S. K. Williamson, N. C. Farneth, P. N. Lara Jr, W. A. Franklin, Q.-T. Le, J. J. Crowley, and D. R. Gandara Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non-Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003 J. Clin. Oncol., October 10, 2008; 26(29): 4771 - 4776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Schepeler, J. T. Reinert, M. S. Ostenfeld, L. L. Christensen, A. N. Silahtaroglu, L. Dyrskjot, C. Wiuf, F. J. Sorensen, M. Kruhoffer, S. Laurberg, et al. Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer Cancer Res., August 1, 2008; 68(15): 6416 - 6424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Shugarman, M. E.S. Sorbero, H. Tian, A. K. Jain, and J. S. Ashwood An Exploration of Urban and Rural Differences in Lung Cancer Survival Among Medicare Beneficiaries Am J Public Health, July 1, 2008; 98(7): 1280 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kaulfuss, M. Grzmil, B. Hemmerlein, P. Thelen, S. Schweyer, J. Neesen, L. Bubendorf, A. G. Glass, H. Jarry, B. Auber, et al. Leupaxin, a Novel Coactivator of the Androgen Receptor, Is Expressed in Prostate Cancer and Plays a Role in Adhesion and Invasion of Prostate Carcinoma Cells Mol. Endocrinol., July 1, 2008; 22(7): 1606 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tsuruta, L. Pereboeva, M. Breidenbach, D. T. Rein, M. Wang, R. D. Alvarez, G. P. Siegal, P. Dent, P. B. Fisher, and D. T. Curiel A Fiber-Modified Mesothelin Promoter-Based Conditionally Replicating Adenovirus for Treatment of Ovarian Cancer Clin. Cancer Res., June 1, 2008; 14(11): 3582 - 3588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S.M. Diefenbach, S. Gnjatic, P. Sabbatini, C. Aghajanian, M. L. Hensley, D. R. Spriggs, A. Iasonos, H. Lee, B. Dupont, S. Pezzulli, et al. Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission Clin. Cancer Res., May 1, 2008; 14(9): 2740 - 2748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Bhosale, M. Patnana, C. Viswanathan, and J. Szklaruk The Inguinal Canal: Anatomy and Imaging Features of Common and Uncommon Masses RadioGraphics, May 1, 2008; 28(3): 819 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kato, N. Sato, A. Takano, M. Miyamoto, H. Nishimura, E. Tsuchiya, S. Kondo, Y. Nakamura, and Y. Daigo Activation of Placenta-Specific Transcription Factor Distal-less Homeobox 5 Predicts Clinical Outcome in Primary Lung Cancer Patients Clin. Cancer Res., April 15, 2008; 14(8): 2363 - 2370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Mandel, J. W. Tanner, G. R. Lichtenstein, D. C. Metz, D. A. Katzka, G. G. Ginsberg, and M. L. Kochman A Randomized, Controlled, Double-Blind Trial of Patient-Controlled Sedation with Propofol/Remifentanil Versus Midazolam/Fentanyl for Colonoscopy Anesth. Analg., February 1, 2008; 106(2): 434 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kocakoc, A. Kiris, I. Orhan, A. K. Poyraz, H. Artas, and F. Firdolas Detection of Bladder Tumors With 3-Dimensional Sonography and Virtual Sonographic Cystoscopy J. Ultrasound Med., January 1, 2008; 27(1): 45 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Tang, T.-W. Tan, W.-M. Fu, and R.-S. Yang Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis Carcinogenesis, January 1, 2008; 29(1): 35 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Taniwaki, A. Takano, N. Ishikawa, W. Yasui, K. Inai, H. Nishimura, E. Tsuchiya, N. Kohno, Y. Nakamura, and Y. Daigo Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung Cancer Clin. Cancer Res., November 15, 2007; 13(22): 6624 - 6631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Y. Kim, M. K. Kee, S. A. Chong, and M. J. Nam Galanin Is Up-Regulated in Colon Adenocarcinoma Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2373 - 2378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Visus, D. Ito, A. Amoscato, M. Maciejewska-Franczak, A. Abdelsalem, R. Dhir, D. M. Shin, V. S. Donnenberg, T. L. Whiteside, and A. B. DeLeo Identification of Human Aldehyde Dehydrogenase 1 Family Member A1 as a Novel CD8+ T-Cell Defined Tumor Antigen in Squamous Cell Carcinoma of the Head and Neck Cancer Res., November 1, 2007; 67(21): 10538 - 10545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Chang, S. J. Mentzer, Y. L. Colson, P. A. Linden, M. T. Jaklitsch, S. R. Lipsitz, and D. J. Sugarbaker Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 850 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sharma, J. Tammela, X. Wang, H. Arnouk, D. Driscoll, P. Mhawech-Fauceglia, S. Lele, A. L. Kazim, and K. Odunsi Characterization of a Putative Ovarian Oncogene, Elongation Factor 1{alpha}, Isolated by Panning a Synthetic Phage Display Single-Chain Variable Fragment Library with Cultured Human Ovarian Cancer Cells Clin. Cancer Res., October 1, 2007; 13(19): 5889 - 5896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, P. Casalini, C. Taccioli, S. Volinia, C.-G. Liu, H. Alder, et al. MicroRNA Signatures in Human Ovarian Cancer Cancer Res., September 15, 2007; 67(18): 8699 - 8707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Coutant, E Barranger, A Cortez, D Dabit, S Uzan, J. Bernaudin, and E Darai Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer Ann. Onc., September 1, 2007; 18(9): 1513 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Kennedy, A. McWilliams, E. Edell, T. Sutedja, G. Downie, R. Yung, A. Gazdar, and P. N. Mathur Bronchial Intraepithelial Neoplasia/Early Central Airways Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 221S - 233S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Cotrim, F. Hyodo, K.-I. Matsumoto, A. L. Sowers, J. A. Cook, B. J. Baum, M. C. Krishna, and J. B. Mitchell Differential Radiation Protection of Salivary Glands versus Tumor by Tempol with Accompanying Tissue Assessment of Tempol by Magnetic Resonance Imaging Clin. Cancer Res., August 15, 2007; 13(16): 4928 - 4933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ohno, H. Koyama, M. Nogami, D. Takenaka, S. Matsumoto, M. Yoshimura, Y. Kotani, and K. Sugimura Postoperative Lung Function in Lung Cancer Patients: Comparative Analysis of Predictive Capability of MRI, CT, and SPECT Am. J. Roentgenol., August 1, 2007; 189(2): 400 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Mutch, M. Orlando, T. Goss, M. G. Teneriello, A. N. Gordon, S. D. McMeekin, Y. Wang, D. R. Scribner Jr, M. Marciniack, R. W. Naumann, et al. Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer J. Clin. Oncol., July 1, 2007; 25(19): 2811 - 2818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Smyth, C. Gourley, G. Walker, M. J. MacKean, A. Stevenson, A. R.W. Williams, A. A. Nafussi, T. Rye, R. Rye, M. Stewart, et al. Antiestrogen Therapy Is Active in Selected Ovarian Cancer Cases: The Use of Letrozole in Estrogen Receptor-Positive Patients Clin. Cancer Res., June 15, 2007; 13(12): 3617 - 3622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. O'Connor, M. C. Farach-Carson, C. J. Schneider, and D. D. Carson Coculture with Prostate Cancer Cells Alters Endoglin Expression and Attenuates Transforming Growth Factor-{beta} Signaling in Reactive Bone Marrow Stromal Cells Mol. Cancer Res., June 1, 2007; 5(6): 585 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zundelevich, G. Elad-Sfadia, R. Haklai, and Y. Kloog Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid) Mol. Cancer Ther., June 1, 2007; 6(6): 1765 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Frederick, B. A. Helfrich, C. D. Coldren, D. Zheng, D. Chan, P. A. Bunn Jr., and D. Raben Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma Mol. Cancer Ther., June 1, 2007; 6(6): 1683 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hayama, Y. Daigo, T. Yamabuki, D. Hirata, T. Kato, M. Miyamoto, T. Ito, E. Tsuchiya, S. Kondo, and Y. Nakamura Phosphorylation and Activation of Cell Division Cycle Associated 8 by Aurora Kinase B Plays a Significant Role in Human Lung Carcinogenesis Cancer Res., May 1, 2007; 67(9): 4113 - 4122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wu, Z. Guo, X. Chang, M. S. Kim, J. K. Nagpal, J. Liu, J. M. Maki, K. I. Kivirikko, S. P. Ethier, B. Trink, et al. LOXL1 and LOXL4 Are Epigenetically Silenced and Can Inhibit Ras/Extracellular Signal-Regulated Kinase Signaling Pathway in Human Bladder Cancer Cancer Res., May 1, 2007; 67(9): 4123 - 4129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-y. Tang, Y.-q. Zhu, W.-h. Tao, B. Wei, and X.-l. Lin Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma Postgrad. Med. J., May 1, 2007; 83(979): 338 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lu, Z. Cai, G. Xiao, E. T. Keller, A. Mizokami, Z. Yao, G. D. Roodman, and J. Zhang Monocyte Chemotactic Protein-1 Mediates Prostate Cancer-Induced Bone Resorption Cancer Res., April 15, 2007; 67(8): 3646 - 3653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Saar, A Meining, A Beer, M Settles, H Helmberger, E Frimberger, E J Rummeny, and T Rosch Prospective study on bright lumen magnetic resonance colonography in comparison with conventional colonoscopy Br. J. Radiol., April 1, 2007; 80(952): 235 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Puppala, C.G. Gairola, and H.I. Swanson Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation Carcinogenesis, March 1, 2007; 28(3): 639 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang and A. Chang Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer J. Med. Genet., March 1, 2007; 44(3): 166 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lagman, N. Rivera, D. Walsh, S. LeGrand, and M. P. Davis Acute Inpatient Palliative Medicine in a Cancer Center: Clinical Problems and Medical Interventions--A Prospective Study American Journal of Hospice and Palliative Medicine, February 1, 2007; 24(1): 20 - 28. [Abstract] [PDF]
|
|
|
|
|
|
C. Suzuki, K. Takahashi, S. Hayama, N. Ishikawa, T. Kato, T. Ito, E. Tsuchiya, Y. Nakamura, and Y. Daigo Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer Mol. Cancer Ther., February 1, 2007; 6(2): 542 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aghdassi, P. Phillips, V. Dudeja, D. Dhaulakhandi, R. Sharif, R. Dawra, M. M. Lerch, and A. Saluja Heat Shock Protein 70 Increases Tumorigenicity and Inhibits Apoptosis in Pancreatic Adenocarcinoma Cancer Res., January 15, 2007; 67(2): 616 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kato, S. Hayama, T. Yamabuki, N. Ishikawa, M. Miyamoto, T. Ito, E. Tsuchiya, S. Kondo, Y. Nakamura, and Y. Daigo Increased Expression of Insulin-like Growth Factor-II Messenger RNA-Binding Protein 1 Is Associated with Tumor Progression in Patients with Lung Cancer Clin. Cancer Res., January 15, 2007; 13(2): 434 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E S Edell High-grade lesion: what does it tell us? Thorax, January 1, 2007; 62(1): 2 - 3. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gill, A. W. Blackstock, and R. M. Goldberg Colorectal Cancer Mayo Clin. Proc., January 1, 2007; 82(1): 114 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ueda, K. Fukamachi, Y. Matsuoka, N. Takasuka, F. Takeshita, A. Naito, M. Iigo, D. B. Alexander, M. A. Moore, I. Saito, et al. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas Carcinogenesis, December 1, 2006; 27(12): 2497 - 2510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kyrgiou, G. Salanti, N. Pavlidis, E. Paraskevaidis, and J. P. A. Ioannidis Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments. J Natl Cancer Inst, November 15, 2006; 98(22): 1655 - 1663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. L. Griffith, A. Melck, S. J.M. Jones, and S. M. Wiseman Meta-Analysis and Meta-Review of Thyroid Cancer Gene Expression Profiling Studies Identifies Important Diagnostic Biomarkers J. Clin. Oncol., November 1, 2006; 24(31): 5043 - 5051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Bloom, S. L. Stewart, I. Oakley-Girvans, P. J. Banks, and S. Chang Family History, Perceived Risk, and Prostate Cancer Screening among African American Men. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2167 - 2173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.J. Mao, W.V. Giannobile, J.A. Helms, S.J. Hollister, P.H. Krebsbach, M.T. Longaker, and S. Shi Craniofacial Tissue Engineering by Stem Cells Journal of Dental Research, November 1, 2006; 85(11): 966 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hayama, Y. Daigo, T. Kato, N. Ishikawa, T. Yamabuki, M. Miyamoto, T. Ito, E. Tsuchiya, S. Kondo, and Y. Nakamura Activation of CDCA1-KNTC2, Members of Centromere Protein Complex, Involved in Pulmonary Carcinogenesis Cancer Res., November 1, 2006; 66(21): 10339 - 10348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Litman, S. Bhasin, C. L. Link, A. B. Araujo, J. B. McKinlay, and for the Boston Area Community Health Survey Invest Serum Androgen Levels in Black, Hispanic, and White Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4326 - 4334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S L El Sharkawy, N F Abbas, M A Badawi, and M A El Shaer Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions J. Clin. Pathol., November 1, 2006; 59(11): 1171 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pectasides, E. Pectasides, A. Psyrri, and T. Economopoulos Treatment Issues in Clear Cell Carcinoma of the Ovary: A Different Entity? Oncologist, November 1, 2006; 11(10): 1089 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xu, L. Ngo, G. Perez, M. Dokmanovic, and P. A. Marks Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor PNAS, October 17, 2006; 103(42): 15540 - 15545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takahashi, C. Furukawa, A. Takano, N. Ishikawa, T. Kato, S. Hayama, C. Suzuki, W. Yasui, K. Inai, S. Sone, et al. The Neuromedin U-Growth Hormone Secretagogue Receptor 1b/Neurotensin Receptor 1 Oncogenic Signaling Pathway as a Therapeutic Target for Lung Cancer Cancer Res., October 1, 2006; 66(19): 9408 - 9419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li and B. C. Tai RNASEL Gene Polymorphisms and the Risk of Prostate Cancer: a Meta-analysis. Clin. Cancer Res., October 1, 2006; 12(19): 5713 - 5719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Munday, M. M. Brennan, and M. Kiupel Altered Expression of {beta}-catenin, E-cadherin, Cycloxygenase-2, and p53 Protein by Ovine Intestinal Adenocarcinoma Cells. Vet. Pathol., September 1, 2006; 43(5): 613 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chung, D. Liou, S. Karlan, A. Waxman, K. Fujimoto, M. Hagiike, and E. H. Phillips Preoperative FDG-PET for Axillary Metastases in Patients With Breast Cancer Arch Surg, August 1, 2006; 141(8): 783 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q.-a. Yuan, H. H. Simmons, M. K. Robinson, M. Russeva, W. A. Marasco, and G. P. Adams Development of engineered antibodies specific for the Mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer. Mol. Cancer Ther., August 1, 2006; 5(8): 2096 - 2105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O. Hoque, S. Begum, O. Topaloglu, A. Chatterjee, E. Rosenbaum, W. Van Criekinge, W. H. Westra, M. Schoenberg, M. Zahurak, S. N. Goodman, et al. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. J Natl Cancer Inst, July 19, 2006; 98(14): 996 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Chung, T. Braunschweig, N. Hu, M. Roth, J. L. Traicoff, Q.-H. Wang, V. Knezevic, P. R. Taylor, and S. M. Hewitt A multiplex tissue immunoblotting assay for proteomic profiling: a pilot study of the normal to tumor transition of esophageal squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1403 - 1408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Cappuzzo, L. Toschi, G. Tallini, G. L. Ceresoli, I. Domenichini, S. Bartolini, G. Finocchiaro, E. Magrini, G. Metro, A. Cancellieri, et al. Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib Ann. Onc., July 1, 2006; 17(7): 1120 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, Y. Wang, R. Yao, R. A. Lubet, and M. You p53 Transgenic Mice Are Highly Susceptible to 4-Nitroquinoline-1-Oxide-Induced Oral Cancer Mol. Cancer Res., June 1, 2006; 4(6): 401 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Neugut, M. Matasar, X. Wang, R. McBride, J. S. Jacobson, W.-Y. Tsai, V. R. Grann, and D. L. Hershman Duration of Adjuvant Chemotherapy for Colon Cancer and Survival Among the Elderly J. Clin. Oncol., May 20, 2006; 24(15): 2368 - 2375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yang, C. E. Bohl, V. A. Nair, S. M. Mustafa, S. S. Hong, D. D. Miller, and J. T. Dalton Preclinical Pharmacology of a Nonsteroidal Ligand for Androgen Receptor-Mediated Imaging of Prostate Cancer J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 402 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Anderson, J. S. Jacobson, D. F. Heitjan, J. G. Zivin, D. Hershman, A. I. Neugut, and V. R. Grann Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann Intern Med, March 21, 2006; 144(6): 397 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gelbard, C. T. Garnett, S. I. Abrams, V. Patel, J. S. Gutkind, C. Palena, K.-Y. Tsang, J. Schlom, and J. W. Hodge Combination Chemotherapy and Radiation of Human Squamous Cell Carcinoma of the Head and Neck Augments CTL-Mediated Lysis. Clin. Cancer Res., March 15, 2006; 12(6): 1897 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bratasz, N. M. Weir, N. L. Parinandi, J. L. Zweier, R. Sridhar, L. J. Ignarro, and P. Kuppusamy Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin PNAS, March 7, 2006; 103(10): 3914 - 3919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Pectasides, M. Pectasides, and T. Economopoulos Brain metastases from epithelial ovarian cancer: a review of the literature. Oncologist, March 1, 2006; 11(3): 252 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Becton, G. V. Dahl, Y. Ravindranath, M. N. Chang, F. G. Behm, S. C. Raimondi, D. R. Head, K. C. Stine, N. J. Lacayo, B. I. Sikic, et al. Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421 Blood, February 15, 2006; 107(4): 1315 - 1324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
International Breast Cancer Study Group Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of International Breast Cancer Study Group Trial 10-93 J. Clin. Oncol., January 20, 2006; 24(3): 337 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tassi, R. T. Henke, E. T. Bowden, M. R. Swift, D. P. Kodack, A. H. Kuo, A. Maitra, and A. Wellstein Expression of a Fibroblast Growth Factor-Binding Protein during the Development of Adenocarcinoma of the Pancreas and Colon Cancer Res., January 15, 2006; 66(2): 1191 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Valmori, F. Qian, M. Ayyoub, C. Renner, A. Merlo, S. Gjnatic, E. Stockert, D. Driscoll, S. Lele, L. J. Old, et al. Expression of Synovial Sarcoma X (SSX) Antigens in Epithelial Ovarian Cancer and Identification of SSX-4 Epitopes Recognized by CD4+ T Cells Clin. Cancer Res., January 15, 2006; 12(2): 398 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. d. O. Santos, C. R. Cernea, M. Inoue, and A. R. Ferraz Selective Neck Dissection for Node-Positive Necks in Patients With Head and Neck Squamous Cell Carcinoma: A Word of Caution Arch Otolaryngol Head Neck Surg, January 1, 2006; 132(1): 79 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gronborg, T. Z. Kristiansen, A. Iwahori, R. Chang, R. Reddy, N. Sato, H. Molina, O. N. Jensen, R. H. Hruban, M. G. Goggins, et al. Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach Mol. Cell. Proteomics, January 1, 2006; 5(1): 157 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wang, J. Hayashi, and G. Serrero PC Cell-Derived Growth Factor Confers Resistance to Dexamethasone and Promotes Tumorigenesis in Human Multiple Myeloma Clin. Cancer Res., January 1, 2006; 12(1): 49 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Suzuki, Y. Daigo, N. Ishikawa, T. Kato, S. Hayama, T. Ito, E. Tsuchiya, and Y. Nakamura ANLN Plays a Critical Role in Human Lung Carcinogenesis through the Activation of RHOA and by Involvement in the Phosphoinositide 3-Kinase/AKT Pathway Cancer Res., December 15, 2005; 65(24): 11314 - 11325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kitagawa, J. Dai, J. Zhang, J. M. Keller, J. Nor, Z. Yao, and E. T. Keller Vascular Endothelial Growth Factor Contributes to Prostate Cancer-Mediated Osteoblastic Activity Cancer Res., December 1, 2005; 65(23): 10921 - 10929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Stearman, L. Dwyer-Nield, L. Zerbe, S. A. Blaine, Z. Chan, P. A. Bunn Jr., G. L. Johnson, F. R. Hirsch, D. T. Merrick, W. A. Franklin, et al. Analysis of Orthologous Gene Expression between Human Pulmonary Adenocarcinoma and a Carcinogen-Induced Murine Model Am. J. Pathol., December 1, 2005; 167(6): 1763 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nathansohn, J. Schachter, and H. Gutman Patterns of Recurrence in Patients With Melanoma After Radical Lymph Node Dissection Arch Surg, December 1, 2005; 140(12): 1172 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Munden, S. S. Swisher, C. W. Stevens, and D. J. Stewart Imaging of the Patient with Non-Small Cell Lung Cancer Radiology, December 1, 2005; 237(3): 803 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-Y. Lee, S.-H. Oh, J. K. Woo, W.-Y. Kim, C. S. Van Pelt, R. E. Price, D. Cody, H. Tran, J. M. Pezzuto, R. M. Moriarty, et al. Chemopreventive Effects of Deguelin, a Novel Akt Inhibitor, on Tobacco-Induced Lung Tumorigenesis J Natl Cancer Inst, November 16, 2005; 97(22): 1695 - 1699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fan, M. Zhou, M. K. Pathak, D. J. Lindner, C. Z. Altuntas, V. K. Tuohy, E. C. Borden, and T. Yi Sodium Stibogluconate Interacts with IL-2 in Anti-Renca Tumor Action via a T Cell-Dependent Mechanism in Connection with Induction of Tumor-Infiltrating Macrophages J. Immunol., November 15, 2005; 175(10): 7003 - 7008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-M. Tu, J. Kim, L. C. Pagliaro, F. Vakar-Lopez, F. C. Wong, S. Wen, R. General, D. A. Podoloff, S.-H. Lin, and C. J. Logothetis Therapy Tolerance in Selected Patients With Androgen-Independent Prostate Cancer Following Strontium-89 Combined With Chemotherapy J. Clin. Oncol., November 1, 2005; 23(31): 7904 - 7910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fabbri, D. Iliopoulos, F. Trapasso, R. I. Aqeilan, A. Cimmino, N. Zanesi, S. Yendamuri, S.-Y. Han, D. Amadori, K. Huebner, et al. WWOX gene restoration prevents lung cancer growth in vitro and in vivo PNAS, October 25, 2005; 102(43): 15611 - 15616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gallardo, B. Rubio, L. Villanueva, and O. Barajas Gallbladder Cancer, a Different Disease that Needs Individual Trials J. Clin. Oncol., October 20, 2005; 23(30): 7753 - 7754. [Full Text] [PDF]
|
|
|
|
 |
|
 R Houghton and G Rottenberg Testicular lumps Imaging, October 1, 2005; 17(2): 101 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Balch, P. Yan, T. Craft, S. Young, D. G. Skalnik, T. H-M. Huang, and K. P. Nephew Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer Mol. Cancer Ther., October 1, 2005; 4(10): 1505 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wang and M. You Five Loci, SLT1 to SLT5, Controlling the Susceptibility to Spontaneously Occurring Lung Cancer in Mice Cancer Res., September 15, 2005; 65(18): 8158 - 8165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Lin, S.-C. Chen, H.-K. Chang, S. Hsueh, C.-S. Tsai, Y.-F. Lo, T.-L. Hwang, and M.-F. Chen Identifying Good Prognosis Group of Breast Cancer Patients with 1-3 Positive Axillary Nodes for Adjuvant Cyclophosphamide, Methotrexate and 5-Fluorouracil (CMF) Chemotherapy Jpn. J. Clin. Oncol., September 1, 2005; 35(9): 514 - 519. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
